Gaelic Laboratories, a world-class manufacturer of Beta-Lactam (penicillin) products, today announces its acquisition of Athlone Laboratories, a leading developer and manufacturer of oral dose Beta-Lactams, in a step that strengthens Gaelic’s market position, enhances manufacturing capabilities, and leverages supply chain efficiencies.
Thanks to its business-friendly climate and stable political environment, which actively supports the pharmaceutical industry, Ireland is now a global hub for pharmaceutical manufacturing. This merger of the country’s two leading producers of Beta-Lactam products presents significant opportunities for future growth and enhanced efficiencies, yielding significant benefits for both companies, their stakeholders, partners and customers.
Both Gaelic Labs and Athlone are well established pharmaceutical
manufacturers with strong reputations in Beta-Lactam antibiotics. Combining the
two companies’ complementary offerings is expected to enable them both to strengthen
their market presence, enhance product offerings, and drive operational
efficiencies. The acquisition also aligns with Gaelic
Labs' long-term vision to establish itself as a leader in the pharmaceutical
industry, particularly in the production and distribution of Beta Lactam
generic medicines.
“The deal is
expected to deliver multiple financial and operational benefits, including cost
savings through manufacturing consolidation, revenue growth and increased
regulatory advantages,” says Brian Morrissey, General Manager of Gaelic Labs. “Athlone
is a key player in the supply chain for Beta-Lactam antibiotics, so they are a
great match for Gaelic Labs, and we will leverage many operational synergies.”
Gaelic Labs is
committed to retaining personnel at the Athlone Labs site, including the
current management team, ensuring operational continuity and a seamless
transition for partners, suppliers and customers. Athlone’s C-suite will now
report to Brian Morrisey, who will have hierarchical responsibility over both
companies.
“Gaelic Labs has always supported the creation of highly-skilled jobs in Ireland,”
adds Brian. “With this acquisition, our total workforce has more than doubled
to around 120 people, and we know that those people are the driving force
behind our success. We are conducting several programs for smooth operational
transitioning, and to ensure we retain the experience and expertise that
Athlone has become known for.”
All existing product lines and customer contracts are expected to
continue without disruption. Looking ahead, for customers of both companies,
the acquisition is expected to bring advantages in terms of greater
efficiencies, backed by investment from Gaelic Labs – which itself benefited
from newly upgraded facilities two years ago – with a view to expanding
both companies’ manufacturing capabilities and market presence, optimizing
manufacturing processes, diversifying product portfolios, and aligning IT and
compliance systems.
For more
information about Gaelic Laboratories and Athlone laboratories, visit their
websites at https://gaeliclabs.com and https://www.athlone-laboratories.com,
respectively.
Editor’s Note For more information, please contact Tristan Jervis at Impact Shine
Communications on +44 (0) 771 363 8396 or e-mail: t.jervis@impactshinecommunications.com.
About Gaelic Laboratories Gaelic
Laboratories is a world-class manufacturer of Beta-Lactam (penicillin) products
in tablet, capsule and powder for suspension form. Established in Ireland in
2022, and with newly upgraded facilities, we manufacture our own Beta-Lactam products
(sold under the Gaelic Laboratories brand), as well as offering contract
manufacturing and packaging services for markets across the EU, UK, the Middle
East and North Africa. Our site in Ireland is licenced
by the HPRA. For more information about Gaelic
Laboratories, please visit https://gaeliclabs.com. About Athlone Laboratories Athlone Laboratories a leading developer and manufacturer of a broad
range of oral dose beta-lactam products. Established in 1974, the company is an
accredited supplier to local and many blue-chip customer partners across
Europe, Asia-Pacific, Canada, Iraq and Brazil Our site
in Ireland is licenced by the HPRA. For more
information about Athlone Laboratories, please visit https://www.athlone-laboratories.com.
